SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001618058-18-000001
Filing Date
2018-03-08
Accepted
2018-03-08 16:46:31
Documents
1
Group Members
COGNITIVE RESEARCH ENTERPRISES, INC.NEUROSCIENCE RESEARCH VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 FORM 13GA neuro.txt SC 13G/A 6021
  Complete submission text file 0001618058-18-000001.txt   7735
Mailing Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Subject) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88549 | Film No.: 18677097
SIC: 2834 Pharmaceutical Preparations

Mailing Address 364 PATTESON DRIVE, #279 MORGANTOWN WV 26505
Business Address 364 PATTESON DRIVE, #279 MORGANTOWN WV 26505 304-598-8112
Neurosciences Research Ventures, Inc. (Filed by) CIK: 0001618058 (see all company filings)

IRS No.: 550771180 | State of Incorp.: WV | Fiscal Year End: 1231
Type: SC 13G/A